Search results for "ARTERIAL"

showing 10 items of 714 documents

Arterial stiffness in obese CPAP-treated obstructive sleep apnea (OSA): A seven years prospective longitudinal study

2017

Introduction: Arterial stiffness measured by carotid-femoral pulse wave velocity (PWV) is elevated in severe OSA. A 1m/s increase in PWV is associated with a 15% increased risk of mortality. There is a paucity of data regarding long term evolution of PWV in CPAP-treated OSA. Aims: To measure PWV evolution in CPAP-treated OSA. Methods: In a prospective obese OSA cohort, we collected PWV, clinical and biological metabolic data, incident cardiovascular events and CPAP adherence at time of diagnosis and after at least 5-year follow-up. Results: 72 OSA (men: 52.8%, median age: 55.8 years and median BMI of 38.5 kg/m2) with a high prevalence of hypertension: 58.3%, Type 2 diabetes: 20.8%, hypercho…

medicine.medical_specialtyCOPDeducation.field_of_studybusiness.industryPopulationType 2 diabetesmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaWeight lossInternal medicineCohortcardiovascular systemmedicineCardiologyArterial stiffnesscardiovascular diseasesmedicine.symptombusinesseducationPulse wave velocitycirculatory and respiratory physiologySleep and Control of Breathing
researchProduct

Texture analysis on preoperative contrast-enhanced magnetic resonance imaging identifies microvascular invasion in hepatocellular carcinoma

2019

Abstract Background Radiomic texture analysis quantifies tumor heterogeneity. The aim of this study is to determine if radiomics can predict biologic aggressiveness in HCC and identify tumors with MVI. Methods Single-center, retrospective review of HCC patients undergoing resection/ablation with curative intent from 2009 to 2017. DICOM images from preoperative MRIs were analyzed with texture analysis software. Texture analysis parameters extracted on T1, T2, hepatic arterial phase (HAP) and portal venous phase (PVP) images. Multivariate logistic regression analysis evaluated factors associated with MVI. Results MVI was present in 52.2% (n = 133) of HCCs. On multivariate analysis only T1 mea…

medicine.medical_specialtyCarcinoma HepatocellularMultivariate analysisHepatocellular carcinoma030230 surgeryLogistic regressionTumor heterogeneity03 medical and health sciences0302 clinical medicinemedicineHumansAnalysis softwareNeoplasm InvasivenessContrast-enhanced Magnetic Resonance ImagingRetrospective StudiesHepatologybusiness.industryLiver NeoplasmsGastroenterologymedicine.diseaseMagnetic Resonance Imaging030220 oncology & carcinogenesisHepatocellular carcinomaRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaArterial phasePreoperative imagingMRI
researchProduct

Requirements on resolution of digital imaging equipment in the cardiac catheterization laboratory.

1988

We evaluated the requirements on spatial resolution of digital imaging equipment in the cardiac catheterization laboratory. Fifty cinefilms of the heart as the biological object and one film of a lead-ladder-pattern as an objective test were used. The patient films were examined for the visibility of the left ventricular angiogram, coronary arterial tree, coronary artery lesions, branching of septal arteries and the number of septal arteries. All films were viewed three times: with a 625 line TV-system, with a 1249 line TV-system and with a cineprojector. It was found that two application areas with different demands on the spatial and temporal resolution can be distinguished: 1) low spatia…

medicine.medical_specialtyCardiac CatheterizationCoronary arterial treebusiness.industrymedicine.medical_treatmentDigital imagingAngiographyCoronary AngiographyRadiographic Image Enhancementmedicine.anatomical_structureApplication areasTemporal resolutionmedicineCineangiographyHumansRadiology Nuclear Medicine and imagingTelevisionRadiologyCardiology and Cardiovascular MedicinebusinessImage resolutionCardiac imagingCardiac catheterizationArteryInternational journal of cardiac imaging
researchProduct

A mathematical model of cardiovascular dynamics for the diagnosis and prognosis of hemorrhagic shock

2020

Abstract A variety of mathematical models of the cardiovascular system have been suggested over several years in order to describe the time-course of a series of physiological variables (i.e. heart rate, cardiac output, arterial pressure) relevant for the compensation mechanisms to perturbations, such as severe haemorrhage. The current study provides a simple but realistic mathematical description of cardiovascular dynamics that may be useful in the assessment and prognosis of hemorrhagic shock. The present work proposes a first version of a differential-algebraic equations model, the model dynamical ODE model for haemorrhage (dODEg). The model consists of 10 differential and 14 algebraic e…

medicine.medical_specialtyCardiac outputMean arterial pressureShock HemorrhagicSettore ING-INF/01 - ElettronicaCardiovascular SystemGeneral Biochemistry Genetics and Molecular Biologycardiovascular dynamicshemorrhagic shockHeart RateInternal medicineHeart ratemedicineQuantitative assessmentAnimalsmathematical modellingCardiac OutputGeneral Environmental SciencePharmacologyGeneral Immunology and MicrobiologyMathematical modelbusiness.industryApplied MathematicsGeneral NeuroscienceSettore ING-IND/34 - Bioingegneria IndustrialeExperimental dataGeneral MedicineModels Theoreticalhemorrhagic shock;Blood pressureModeling and SimulationSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaHemorrhagic shockCardiologybusinessMathematical Medicine and Biology: A Journal of the IMA
researchProduct

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (…

2017

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) : Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries

medicine.medical_specialtyCarotid artery diseasebusiness.industryAtherosclerotic diseaseUpper extremity artery diseaseGuideline030204 cardiovascular system & hematologyVascular surgeryLower extremity artery diseaseMultisite artery diseasePeripheral Arterial Diseases3. Good health03 medical and health sciences0302 clinical medicineRenal artery diseaseInternal medicinePeripheral arterial diseasemedicineCardiologyMesenteric artery disease030212 general & internal medicineVertebral artery diseaseCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Intraarterielle präoperative Chemotherapie fortgeschrittener Zervixkarzinome

1991

Three patients suffering from very advanced primary cancers of the cervix uteri (FIGO II B or III B) were treated. By preoperative selective perfusion of both uterine arteries, using cis-platinum alone, a distinct reduction of the tumour volume was achieved. This was demonstrated clinically and also by CAT scan and NMR technique. The elevated serum CEA and SCC levels decreased to normal values. The histomorphology of the Wertheim-Meigs specimens revealed no tumour invasion of the initially infiltrated parametria. This treatment modality has been developed to minimise the toxic side effects of the inductive (neo-adjuvant) chemotherapy for cervical cancers.

medicine.medical_specialtyChemotherapyPathologybusiness.industrymedicine.medical_treatmentObstetrics and GynecologyCancerNormal valuesmedicine.diseaseElevated serummedicine.anatomical_structureMaternity and MidwiferymedicineIntra arterialPreoperative chemotherapyRadiologybusinessPerfusionCervixGeburtshilfe und Frauenheilkunde
researchProduct

Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study

2018

BACKGROUND Cirrhosis is associated with morpho-functional cardiovascular alterations. AIMS To detect early features of cardiovascular damage in HCV-compensated cirrhotic patients using myocardial deformation indices and carotid arterial stiffness, and, further, to evaluate their short-term behaviour after HCV eradication with direct antiviral agents (DAAs). METHODS Thirty-nine consecutive patients with HCV cirrhosis, without previous cardiovascular events, were studied and matched for age, gender and cardiovascular risk factors to 39 controls without liver or cardiovascular disease. Patients and controls underwent a baseline echocardiographic evaluation including global longitudinal strain …

medicine.medical_specialtyCirrhosisSettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyHepatitis C030204 cardiovascular system & hematologycardiovascular damage cirrhosis HCV global longitudinal strainmedicine.disease03 medical and health sciencesLiver disease0302 clinical medicineInternal medicineDiabetes mellitusArterial stiffnessCardiologyMedicine030211 gastroenterology & hepatologyPharmacology (medical)businessProspective cohort studyPulse wave velocitySubclinical infection
researchProduct

Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice.

2020

Nonalcoholic fatty liver disease (NAFLD) is a clinical condition that encompasses various forms of liver damage not caused by chronic alcohol consumption. In the absence of other etiologies, it ranges from ste- atosis to nonalcoholic steatohepatitis and cirrhosis. The prevalence of NAFLD has considerably increased over the last years owing to the current lifestyle (unhealthy diet and sedentarism). Besides, it is associated with metabolic risk factors such as obesity, arterial hypertension, dyslipidemia, and type 2 diabetes. Given the poor prognosis of patients with advanced NAFLD, a practical therapeutic approach is necessary to halt its natural history. However, no licensed drugs have been…

medicine.medical_specialtyCirrhosisbusiness.industrynutritional and metabolic diseasesDiseaseType 2 diabetesComorbiditymedicine.diseaseObesitydigestive system diseasesArterial hypertension Dyslipidemia Nonalcoholic fatty liver disease Type 2 diabetes Comorbidity Humans Obesity Weight Loss Diabetes Mellitus Type 2 Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus Type 2Weight lossNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseaseWeight LossInternal MedicinemedicineHumansObesitymedicine.symptomSteatosisbusinessDyslipidemiaPolish archives of internal medicine
researchProduct

The Role for Combined Antithrombotic Therapy with Platelet and Coagulation Inhibition After Lower Extremity Revascularization

2021

Evidence for antithrombotic treatment following lower extremity revascularization (LER) for peripheral artery disease (PAD) is limited, leading to weak and conflicting guideline recommendations and heterogeneous practice patterns. This variability in post-LER antithrombotic treatment raises quality-of-care issues that have long been under-studied. This Viewpoint reviews the most updated guidelines, currently-available evidence, and contemporary data about practice patterns and practitioner opinions in this area. Particular attention is paid to distinctions between antiplatelet therapy, anticoagulant therapy, and combination therapy in light of the recent VOYAGER-PAD (Vascular Outcomes Study…

medicine.medical_specialtyCombination therapymedicine.drug_classDisease030204 cardiovascular system & hematologyArticle03 medical and health sciencesPeripheral Arterial Disease0302 clinical medicineFibrinolytic AgentsAntithromboticmedicineHumansPlatelet030212 general & internal medicineIntensive care medicineRivaroxabanbusiness.industryAnticoagulantfood and beveragesGuidelineTreatment OutcomeCoagulationLower ExtremityCardiology and Cardiovascular MedicinebusinessVascular Surgical Proceduresmedicine.drug
researchProduct

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral …

2021

AbstractThe aim of this collaborative document is to provide an update for clinicians on best antithrombotic strategies in patients with aortic and/or peripheral arterial diseases. Antithrombotic therapy is a pillar of optimal medical treatment for these patients at very high cardiovascular risk. While the number of trials on antithrombotic therapies in patients with aortic or peripheral arterial diseases is substantially smaller than for those with coronary artery disease, recent evidence deserves to be incorporated into clinical practice. In the absence of specific indications for chronic oral anticoagulation due to concomitant cardiovascular disease, a single antiplatelet agent is the ba…

medicine.medical_specialtyConsensusAntiplatelet drugmedicine.drug_classmedicine.medical_treatmentDisease030204 cardiovascular system & hematologyCoronary artery diseasePeripheral Arterial Disease03 medical and health sciences0302 clinical medicinePharmacotherapyFibrinolytic AgentsAntithromboticmedicineHumansIntensive care medicineAortabusiness.industryAnticoagulantAnticoagulantsThrombosismedicine.diseaseThrombosisCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitors030217 neurology & neurosurgeryFibrinolytic agentEuropean Heart Journal
researchProduct